Patchoulol is one of the compounds supporting the aroma of patchouli essential oil. Researchers are also exploring production by yeast instead of extraction from plants. Yet strengthening a cell’s ability to make the compound does not necessarily make it easy to recover.
A study published by Danni Fu and colleagues in 2026 combined the enzyme that makes patchoulol, metabolic pathways supplying its starting materials, and proteins that transport substances across cell membranes to improve production in yeast. A particular focus was incorporating export of the product into the production design.
Installing a plant enzyme in yeast
The organism used was Saccharomyces cerevisiae, the yeast familiar from baking and brewing. The researchers integrated a patchouli plant’s patchoulol synthase gene into the yeast chromosomes. The enzyme converts an intermediate naturally produced by yeast into patchoulol.
Patchoulol was detectable in the initial strain, but its concentration remained low. The team therefore replaced some of the enzyme’s amino acids to search for variants with higher production. Computational predictions of how the enzyme contacts its substrate also informed candidate selection.
Not every modification succeeded. Some reduced the target compound, while others shifted production toward another aroma compound, α-bulnesene. Altering an enzyme can change not only how much it produces but also which product the reaction favors.
Balancing material supply and the cell’s own growth
Next, the team improved the pathway supplying starting materials within yeast. This pathway uses several enzymes to assemble small molecules derived from sugars and other sources into the immediate precursor of patchoulol. Strengthening pathway flux and adding multiple copies of the synthase gene increased production.
These materials are also used to make components needed by the yeast itself. For example, the pathway leading to sterols that support membrane function competes with the patchoulol pathway for the same intermediate.
The researchers adjusted the activity of ERG9, a gene in the competing pathway, to direct more material toward patchoulol. Reducing essential cellular components too far, however, can hamper growth. Increasing product formation and growing enough yeast must be reconciled.
A strain combining these modifications reached a reported patchoulol concentration of approximately 259 mg/L in flask experiments. The study then went further by modifying transport.
Helping the product leave the cell
Patchoulol has low affinity for water. It may tend to remain in cell membranes or lipid-rich locations within cells, and excessive accumulation could place a burden on them.
The team therefore investigated transporters, proteins that move substances across cell membranes. They computationally predicted possible interactions between several transporters and patchoulol and measured how much RNA was produced from the corresponding genes in the production strain. RNA abundance provides a clue to the activity of a gene.
When candidates were overexpressed in yeast, a strain with increased expression of the transporter PDR12 reached a reported concentration of approximately 373 mg/L. This exceeded the approximately 259 mg/L of the strain before that modification.
This alone does not reveal how much patchoulol PDR12 transports per second. The experiments did not directly measure transport rates, the energy consumed, or the amounts partitioned inside and outside cells. Taken together, however, the computations, RNA changes, and overexpression results support an interpretation in which PDR12 contributes to improved recovery.
With another transporter, an increase in target product could coincide with a decrease in yeast biomass. Overproducing any transporter is not automatically advantageous; the burden on the cell also has to be considered.
Where was the patchoulol behind those numbers measured?
The study added a layer of dodecane, an organic liquid that separates from water, to the predominantly aqueous culture medium. This two-phase arrangement, resembling separated oil and water, collects poorly water-soluble patchoulol in the organic layer to facilitate recovery.
For analysis, the researchers sampled the dodecane layer and used gas chromatography–mass spectrometry. The methods explicitly state that reported concentrations were quantified from this organic phase; material remaining in the aqueous phase or inside cells was not quantified. The approximately 259 mg/L and 373 mg/L values must be read in this analytical sense.
They are therefore neither a count of all patchoulol throughout the culture nor the mass recovered as purified product. The measurement involves synthesis, export, and transfer into the organic phase for recovery.
In controls without dodecane, patchoulol in the culture medium was not detectable under the analytical conditions used. This suggests that the organic phase is important for recovery, but does not mean that the cells produced none or that none existed inside them.
Separating growth and production stages in a 5 L vessel
The improved strain was also tested in a fermenter with a 5 L capacity. The initial medium volume was 2 L, with nutrients added during cultivation. A two-stage process first grew the yeast and then changed sugar type and supply to encourage production. Recovery into an organic phase was also included.
After 168 hours, or 7 days, the reported patchoulol concentration reached approximately 2.86 g/L. This too was quantified from the organic phase. It cannot be restated as the final recovery of 2.86 g of purified product from each liter of culture broth.
Cell growth still faced limitations. The authors discuss possible roles for suppressed sterol synthesis, patchoulol or ethanol accumulation, and nutrient or oxygen conditions. They did not conclusively establish every contribution, but the discussion points to the need to adjust growth and production over time.
A different goal from recreating essential oil
The target here was the single compound patchoulol. The study did not recreate the complete aroma of multicomponent patchouli essential oil in yeast. Nor did it assess sensory equivalence in humans, finished-product quality, manufacturing costs, or environmental impacts from raw-material sourcing through purification.
For future work, the authors propose measuring intracellular amounts and further adjusting transporters, membrane properties, precursor and cofactor supply, and two-phase extraction conditions. Adding another production route to supplies dependent on plant cultivation and extraction has potential value, but practical advantages must be established by considering these additional factors.
The work was supported by the National Natural Science Foundation of China and a Guangdong provincial basic-research program. The authors declare no known competing financial interests or personal relationships that could have influenced the research.
Summary
Improving patchoulol-producing yeast involved not only enzymes and material flows but also membrane transport and recovery from the culture. Experiments increasing PDR12 expression show the value of incorporating transport design into metabolic design.
The implication is that microbial fragrance production should not be treated as ending with synthesis inside the cell. It also requires maintaining cellular growth and arranging effective product recovery. This approach could extend to other poorly water-soluble fragrance compounds beyond patchoulol.
References
Fu, D., Zhou, Y., Wu, Z., Wang, S., Lao, Y., Wang, H.-B., & Jin, H.-L.(2026). Metabolic and transport engineering enable efficient de novo biosynthesis of patchoulol in Saccharomyces cerevisiae. Synthetic and Systems Biotechnology, 13, 196–204. DOI: 10.1016/j.synbio.2026.01.026.Full original article.
Original article: © 2026 The Authors. Published under CC BY-NC-ND 4.0.
